Author: alarpharm

Media releases

2023/10/12 Receives the notice of exercising the Option in the license agreement of ALA-1000 and related products from INDIVIOR UK LIMITED

Comments Off on 2023/10/12 Receives the notice of exercising the Option in the license agreement of ALA-1000 and related products from INDIVIOR UK LIMITED

12 . 10 . 2023

Media releases

2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S)

Comments Off on 2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S)

23 . 8 . 2023

Media releases

2023/08/07 ALA-3000 has received an Resolution of acceptance to registration from Instituto Nacional de Propiedad Industrial (INAPI)-Chile after the examination. (Patent Application No. 202101803)

Comments Off on 2023/08/07 ALA-3000 has received an Resolution of acceptance to registration from Instituto Nacional de Propiedad Industrial (INAPI)-Chile after the examination. (Patent Application No. 202101803)

10 . 8 . 2023

Media releases

2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5)

Comments Off on 2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5)

10 . 8 . 2023

Media releases

2023/07/25 ALA-3000 Received the patent, KETAMINE PAMOATE AND USE THEREOF from China National Intellectual Property Administration (CNIPA) , NO : 202080007207.5

Comments Off on 2023/07/25 ALA-3000 Received the patent, KETAMINE PAMOATE AND USE THEREOF from China National Intellectual Property Administration (CNIPA) , NO : 202080007207.5

26 . 7 . 2023

Media releases

2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B

Comments Off on 2023/07/19 ALA-1300 Received the patent, LONG-ACTING INJECTABLE FORMULATIONS AND CRYSTALLINE FORMS OF BUPRENORPHINE DERIVATIVES , from Directorate General of Intellectual Property Rights (DGIP) of Indonesia, NO IDP 000 087828 B

26 . 7 . 2023